In partnership with
Onsemi Acquires Synaptics in ~$7B Deal to Lead Physical AI
Onsemi agreed to acquire Synaptics in an all-stock deal worth roughly $7 billion, with CEO Hassane El-Khoury declaring it will "create a market leader in what is to be known as the physical AI realm." The deal expands Onsemi's total addressable market by $30 billion to $243 billion by 2030. It's a signal that the next AI battleground isn't in the cloud — it's in the sensors, chips, and edge devices embedded in machines and factories.
IBM Unveils the World's First Sub-1nm Chip
IBM announced a 0.7nm chip packing roughly 100 billion transistors onto a fingernail-sized die — claiming up to 50% higher performance or 70% better energy efficiency versus its current 2nm chip. It's built in Albany, NY, with commercial production projected within five years. If it delivers, this could reshape the economics of AI hardware and reduce U.S. dependence on Taiwan-based chip manufacturing.
White House Asks OpenAI to Gate GPT-5.6 Rollout
At the request of the Office of the National Cyber Director, OpenAI agreed to approve GPT-5.6 access on a customer-by-customer basis during preview, delaying broader release by "a couple of weeks." OpenAI noted it does not believe government vetting "should become the long-term default." The move reflects growing federal anxiety about frontier AI capabilities landing in the wrong hands — and sets a precedent for how powerful models get deployed going forward.
Two Federal Agencies Open Probes into Fatal Tesla FSD Crash
Both the NHTSA and NTSB launched investigations after a Tesla Model 3 operating on automated driving slammed into a home in Katy, Texas, killing a 76-year-old woman. The dual federal action raises the regulatory temperature on autonomous vehicle technology at a moment when the industry is pushing hard for expanded deployment. Every fatal AV incident carries outsized policy consequences — and this one landed at a particularly sensitive time for Tesla.
AbbVie Acquires Apogee Therapeutics for ~$10.9B
AbbVie agreed to acquire clinical-stage biotech Apogee Therapeutics at $135.11 per share, deepening its immunology and respiratory disease pipeline. The deal is one of the largest pharma acquisitions of the year and reflects a broader industry strategy: as Humira biosimilars continue to erode revenue, legacy pharma is spending aggressively to buy next-generation drug pipelines. This is M&A as survival strategy.
ChatGPT Falls Below 50% Global Market Share for the First Time
A Sensor Tower State of AI report found ChatGPT's share of the global AI chatbot market has dropped below 50% for the first time, with Gemini now at 27.7% and Claude at 10.3%. Less than two years ago, ChatGPT had the market largely to itself. The compression of that lead is one of the most consequential competitive shifts in tech right now — and it's happening faster than most predicted.
Coca-Cola vs. IRS: $20 Billion Transfer Pricing Case Hits Appeals Court
The U.S. Court of Appeals for the Eleventh Circuit heard oral arguments on June 25 in Coca-Cola's decade-long battle with the IRS over how it priced intellectual property — including its formula — transferred to foreign subsidiaries in Brazil, Ireland, and Mexico. A loss could cost Coke up to $20 billion in taxes and interest, more than its total net income last year. The outcome will set precedent for how every U.S. multinational prices cross-border IP transactions going forward.
That lead in your CRM? Gone.
Over 3.5 billion people open WhatsApp, Instagram, or Facebook Messenger every day. Your customers are already there, asking questions and comparing options.
Wati puts your business across WhatsApp, Instagram DM, Facebook Messenger, SMS, RCS, and web chat in one AI-powered inbox.
Automations instantly respond, route conversations, and keep every interaction tracked in one place.
Meet customers where they already are, before your competitor does.
Want to reach 40,000+ builders and decision makers? Partner with us.
What'd you think of today's edition?
Was this shared with you?
